Pigment epithelium-derived factor (PEDF) as a therapeutic target in cardiovascular disease

Author： Rychli Kathrin   Huber Kurt   Wojta Johann  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.13, Iss.11, 2009-11, pp. : 1295-1302

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pigment Epithelium-derived Factor (PEDF) and Cardiometabolic Disorders

By  

Current Pharmaceutical Design, Vol. 20, Iss. 14, 2014-04 ,pp. : 2377-2386

Bentham Science Publishers

Access to resources Recommend Favorite

Pigment Epithelium-Derived Factor (PEDF): Its Potential Therapeutic Implication in Diabetic Vascular Complications

By  

Current Drug Targets, Vol. 9, Iss. 11, 2008-11 ,pp. : 1025-1029

Bentham Science Publishers

Access to resources Recommend Favorite

Atheroprotective Properties of Pigment Epithelium-Derived Factor (PEDF) in Cardiometabolic Disorders

By  

Current Pharmaceutical Design, Vol. 15, Iss. 9, 2009-03 ,pp. : 1027-1033

Bentham Science Publishers

Access to resources Recommend Favorite

Pathophysiological Role of Pigment Epithelium-Derived Factor (PEDF) in Hepatic Disorders

By  

Current Medicinal Chemistry, Vol. 17, Iss. 19, 2010-07 ,pp. : 1995-2000

Bentham Science Publishers

Access to resources Recommend Favorite

Aqueous Humour Levels of Asymmetric Dimethylarginine (ADMA) are Correlated with Pigment Epithelium-derived Factor (PEDF) in Patients with Uveitis

By Yoshida Y   Yamagishi S   Ueda S   Yoshimura K   Okuda S   Yamakawa R  

The Journal of International Medical Research, Vol. 35, Iss. 6, 2007-11 ,pp. : 892-895

Field House Publishing

Access to resources Recommend Favorite